Filter by

Drugs (Pharmaceuticals)

Sorted by Most Recent Airing

Showing 1 - 20 of 273 Show 100
  • [alt text]

    Book Discussion on Blood Medicine

    Kathleen Sharp talked about her book, Blood Medicine: Blowing the Whistle on One of the Deadliest Prescription Drugs Ever, about the prescription drug Procrit, also known as…

    207 views
  • [alt text]

    Prescription Drug Market

    Chief executive officers (CEOs) of several pharmaceutical companies and two Food and Drug Administration (FDA) officials testified at a hearing on prescription drug cost increases. The…

    10,430 views
  • [alt text]

    Generic Drug Approval Process and Accessibility

    Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, testified at a hearing on the accessibility of generic drugs. She talked about progress being…

    293 views
  • [alt text]

    Heroin and Prescription Drug Abuse

    Senators Jeanne Shaheen (D-NH), Kelly Ayotte (R-NH) and Rob Portman (R-OH), Governor Peter Shumlin (D-VT), federal drug policy officials, and advocates testified at a hearing on heroin and…

    1,242 views
  • [alt text]

    Book Discussion on Humboldt

    Emily Brady talked about her book, Humboldt: Life on America’s Marijuana Frontier. She described how the growing drive to legalize marijuana was affecting the economy of Humboldt…

    386 views
  • [alt text]

    Drug Control Policy

    Michael Botticelli, director of the Office of National Drug Control Policy (ONDCP), and other federal officials testified at a hearing on the reauthorization of ONDCP and the agency’s…

    359 views
  • [alt text]

    Ian Read on the Pharmaceutical Industry

    Ian Read talked about the pharmaceutical industry, drug prices, government regulation, the U.S. tax code, and the future of the health technology industry. topics included the…

    101 views
  • [alt text]

    Pharmaceutical Purchasing and Management

    Andy Slavitt spoke about pharmaceutical innovation and drug costs. Then, panelists discussed innovative purchasing strategies for the pharmaceutical industry. “Purchasing Strategies…

    155 views
  • [alt text]

    Pharmaceutical Development and Drug Costs

    Health and Human Services Secretary Sylvia Burwell delivered opening remarks at the department’s forum about the development of new pharmaceuticals and concerns about rising drug…

    281 views
  • [alt text]

    Pharmaceutical Purchasing Programs

    Panelists discussed value-based drug purchasing programs and the impact of Food and Drug Administration regulations on drug prices. Then Health and Human Services Health Reform…

    80 views
  • [alt text]

    Patient Access to Drugs Panel

    Panelists shared ideas on improving access to high quality and affordable drugs. “Addressing Patient Access and the Affordability of Prescription Drugs” was part of the…

    89 views
  • [alt text]

    Food and Drug Administration Confirmation Hearing

    Robert Califf testified before the Senate Health, Education, Labor and Pensions Committee on his nomination to be commissioner of the Food and Drug Administration. Many of senators'…

    640 views
  • [alt text]

    Cost of Pharmaceutical Drugs

    Sarah Ferris talked about criticism facing the pharmaceutical industry over skyrocketing drug prices. Topics included the types of drugs on which prices are rising, factors that drive…

    331 views
  • [alt text]

    Health Care Policy Forum

    Panelists made presentations on rising drug prices and efforts to improve the health care system and reduce costs. Then they responded to questions submitted by members of the…

    170 views
  • [alt text]

    Book Discussion on Happy Pills in America

    David Herzberg talked about his book, Happy Pills in America: From Miltown to Prozac, about America’s history with medications which have been considered wonder drugs. In his…

    225 views
  • [alt text]

    Cost of Pharmaceutical Drugs

    Scott Gottlieb talked about the methods used by pharmaceutical companies when determining drug prices, as well as the Food and Drug Administration’s role in the drug market.

    322 views
  • [alt text]

    Prescription Drug Affordability

    Senator Bernie Sanders (I-VT) and Representative Elijah Cummings (D-MD) spoke to reporters about their legislation intended reduce the price of prescription drugs. Senator Sanders also…

    402 views
  • [alt text]

    Medicare Prescription Drug Program

    Two Health and Human Services Department officials testified on reducing fraud and abuse in the Medicare Part D prescription drug for older Americans. The hearing focused specifically…

    163 views
  • [alt text]

    National Institutes of Health Funding and Medical Cures Legislation

    Melanie Zanona was interviewed about a House bill to fund the National Institutes of Health (NIH) and the Food and Drug Administration (FDA). The legislation would also revamp biomedical…

    86 views
  • [alt text]

    Veterans Suicide Risk

    Witnesses testified at a hearing on the heavy reliance on medication by veterans and the possible adverse effects of opioid therapy, including the risk of suicide.

    395 views
  • Load 20 More